CLOV34 trade ideas
CLOV - February 7, 2021CLOV was bought out from a Chamath SPAC, this ticker has been in the headlines recently for investigation by the SEC for upping prices for healthcare services. Look for Chamath tweets and news on the stock to produce movement. From a technical standpoint, if we see a breakout look for resistance around 14.30 and 18 before moving higher with a 6-week price target of 24. Support is around 11.30, invalidation occurs around 12.20. CLOV has earnings coming up on February 25th, 2021 pre-market.
$CLOV Bearish Channels Breakout upward Incoming$CLOV was consolidating after a retracement down. After consolidation and approaching the edge of a wedge indicating a big movement. They were unexpectedly the target of a short sellers report which caused the movement to continue downward. With a well articulated rebuttal the doc was able to rally and bounce back up. We appear to be at the bottom of a bearish channel and will likely retrace back up in the near future a short squeeze caused by any positive catalyst will likely break the channel upward allowing us to retrace upward towards the $14 area. With February 19th options expiring I expect the retracement to happen soon after.
Huge selloff equals great opportunity. In Chammath we trust. This a great company that will change the healthcare industry. There goal is to cut costs and offer innovative software to the healthcare industry. The short seller report is bogus and filled with false information. this is a long hold for me.